Nájdite lekára
Pre zobrazenie najbližšieho lekára začnite vyhľadávaním svojej polohy.
Select Your Region
Latin America
Referencie
1. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
2. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clin Ophthalmol. 2022;16:1541-53.
3. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2321-2328
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. Eur J of Ophthalmol. 2007; 17(1): pp. 1-6.
5. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg., Volume 26 , Issue 9 , 1326 - 1331.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.
7. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
This provider locator tool is being provided by STAAR Surgical® Company (“STAAR”) solely to assist users in locating a provider who has experience with the EVO ICL family of lenses, as explained further here. Specifically, the sole criteria for inclusion in the locator is whether a provider is certified by STAAR to implant EVO ICL lenses. Users may search the locator by zip code, state, or current location. Two types of sorting functionality is available within the locator. Users are able to sort the results via distance, or by the frequency with which a healthcare provider has recently used EVO ICL lenses (e.g., within the past 12 months). Irrespective of the sorting method selected, all providers are shown in the results within the queried geographic location. The listed order of providers under any sorting method, including the initial presentation of providers in a geographic location, is based on a variety of factors, including whether the provider maintains consumer-facing information about EVO ICL lenses on its website, the breadth and quality of such information, whether it has demonstrated a commitment to training staff and offering the EVO ICL as a refractive procedure option to qualified patients, and how frequently the provider has performed procedures using the EVO ICL over the past year.
Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider.
STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool.
Dôležité bezpečnostné informácie pre EVO/EVO+ ICL
EVO/EVO+ ICL je určený na korekciu/zníženie krátkozrakosti do -20 dioptrií (D) a astigmatizmu do 6 D pre pacientov vo veku 21 až 60 rokov, prípadne pre pacientov starších než 21 rokov, ktorí boli už liečení vnútroočnou šošovkou. Implantácia EVO/EVO+ ICL je chirurgický zákrok, a preto so sebou nesie určité riziká. Medzi potenciálne komplikácie/podujatia patria: ďalšie operácie, vznik katarakty, prechodná alebo trvalá strata najlepšej upravenej ostrosti zraku, zvýšený vnútroočný tlak, strata buniek na najvnútornejšom povrchu rohovky, podráždenie spojivky, opuch rohovky, infekcia oka, dislokácie EVO/EVO+ ICL, makulárny edém, nereagujúca zrenička, pupilárny blok, glaukóm, závažný zápal oka, iritída, uveitída, strata sklovca a transplantácia rohovky. Pred zvažovaním zákroku EVO/EVO+ ICL absolvujte kompletné očné vyšetrenie a porozprávajte sa s očným špecialistom o priebehu, zahrňujúc potenciálne prínosy, riziká a možné komplikácie. Porozprávajte sa aj o čase potrebnom na hojenie po zákroku.